Dr. Debra Patt, executive vice president at Texas Oncology, testified during a House subcommittee hearing that the 340B program was "broken."

Congressional Witnesses Urge Medicare 340B Cuts

October 24, 2023 William Newton, Associate Editor/Senior Writer Views

Witnesses recently told a U.S. House subcommittee that Congress should cut Medicare payments for 340B drugs. The House Energy and [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!